Nonresident fellow Hagop Kantarjian examines how the high price of Hepatitis C drugs has made treatment unaffordable, leading to the deaths of up to 500,000 people annually that could prevented. Houston Chronicle: http://bit.ly/2iYq3YX.
Nov. 27, 2017, 10:13 a.m.
Maude Rowland Cuchiara, Ph.D., is a nonresident scholar for the Science and Technology Policy Program. Cuchiara actively ...
Deepak Srivastava, M.D., is the Baker Institute Nonresident Scholar for Biomedical Research Policy. He is the Younger Family ...